Diffuse large B-cell lymphoma presenting with central pontine myelinolysis: a case report
Authors:
- Eri KawataEKEri Kawata
- Reiko IsaRIReiko Isa
- Junko YamaguchiJYJunko Yamaguchi
- Kazuna TanbaKTKazuna Tanba
- Yasuhiko TsutsumiYTYasuhiko Tsutsumi
- Yoshinari NagakaneYNYoshinari Nagakane
- Hitoji UchiyamaHUHitoji Uchiyama
- Teruaki AkaogiTATeruaki Akaogi
- Yutaka KobayashiYKYutaka Kobayashi
- Nobuhiko UoshimaNUNobuhiko Uoshima
Open Access
- 5 June 2015
- journal article
- case report
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 9 (1) , 131
Abstract
The most common cause of central pontine myelinolysis is an overly rapid correction of hyponatremia, although it can also occur in patients with any condition leading to nutritional or electrolyte stress. We report a case of diffuse large B-cell lymphoma with central pontine myelinolysis developing at the onset of disease. To the best of our knowledge, hematological malignancies presenting with central pontine myelinolysis have been rarely reported, especially in previously untreated patients, as in our case report. A 78-year-old Japanese woman presented to a neighborhood clinic with persistent high fever, edema, and general weakness. Despite the absence of specific neurological findings, brain magnetic resonance imaging showed an abnormal lesion in the central pons area of her brain (hyperintense on T2-weighted and hypointense on T1-weighted sequences), compatible with central pontine myelinolysis. She was admitted to our emergency department in a state of shock one month later. The results of her blood tests showed greatly elevated C-reactive protein and lactate dehydrogenase levels. She had severe hypoalbuminemia and mild hyponatremia, and showed signs of disseminated intravascular coagulation. Mild bilateral pleural effusion, prominent subcutaneous edema, and splenomegaly were detected on her systemic computed tomography scan. Her body fluid cultures did not show signs of infection and her spinal aspiration did not show pleocytosis or abnormal cells. A diagnosis of diffuse large B-cell lymphoma was made based on the results of her bone marrow examination. As she was critically ill before the diagnosis was made, she was treated with methylprednisolone pulse therapy, followed by systemic chemotherapy (rituximab with modified THP-COP regimen, including cyclophosphamide, pirarubicin, vindesine, and prednisolone), which resulted in complete remission and recovery without any neurological defects, and resolution of her abnormal findings on magnetic resonance imaging. Central pontine myelinolysis is a serious condition that may result in neuropathological sequelae and mortality, and clinicians should be aware of its potential presence in patients with malignancies.Keywords
This publication has 16 references indexed in Scilit:
- Central pontine myelinolysis in a patient with non‐Hodgkin lymphomaBritish Journal of Haematology, 2013
- Value of diffusion-weighted imaging in central pontine and extrapontine myelinolysisNeuroradiology, 2012
- Clinical and Radiologic Correlations of Central Pontine Myelinolysis SyndromeMayo Clinic Proceedings, 2011
- Hyponatremia: Clinical Diagnosis and ManagementThe American Journal of Medicine, 2007
- Psychotic disorder in a patient with central and extrapontine myelinolysisPsychiatry and Clinical Neurosciences, 2007
- Central and Extrapontine Myelinolysis: Then…and NowJournal of Neuropathology & Experimental Neurology, 2006
- MRI Findings in Osmotic MyelinolysisClinical Radiology, 2002
- Hodgkin's disease associated with central pontine myelinolysisMedical and Pediatric Oncology, 1993
- Central pontine myelinolysis in association with Hodgkin’s lymphomaPostgraduate Medical Journal, 1981
- Central Pontine MyelinolysisA.M.A. Archives of Neurology & Psychiatry, 1959